Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

ChemMaps Lets Researchers Navigate the Chemical Universe

By Tracey Peake, North Carolina State University | June 5, 2018

Researchers from North Carolina State University have created a new online service – ChemMaps – that allows users to interactively navigate the chemical space of over 8,000 drugs and 47,000 environmental compounds in 3D and real time. ChemMaps is designed to be a central resource for students and researchers who want to easily visualize and study complicated sets of chemical structures. The first release of the free-to-use website is available at www.chemmaps.com.

“The premise for ChemMaps was to make it the Google Maps of drugs,” says Denis Fourches, assistant professor of chemistry at NC State. “It allows anyone using a computer or a tablet to easily browse and navigate the chemical space of marketed drugs in a 3D environment. We really wanted to make the graphic interface in ChemMaps relevant for a student or for a specialist in medicinal chemistry.”

With ChemMaps, the chemicals look like stars – points of light scattered across the screen. Each star, or compound, is positioned in relationship to the others within the complex chemical space based on their structural properties. When a user clicks on a particular compound-star, several key characteristics of that chemical are displayed: its systematic name, brand name, chemical structure, medical indication, external identifiers, and other physical chemical properties.

Currently, there are two main maps available. The DrugMap includes around 8,000 drugs (marketed, in development and withdrawn) and was prepared from the DrugBank database. The environmental map, or EnvMap, includes over 47,000 compounds (such as pesticides or flame retardants) of relevance for the National Institute of Environmental Health Studies (NIEHS) and the United States Environmental Protection Agency (EPA) and was prepared from the Tox21, Toxcast, and other NIEHS databases.

The researchers plan to add features over time, including the ability for collaborators and companies to visualize and project proprietary sets of chemicals onto the ChemMaps. They also plan to make the maps even more interactive, easy to manipulate, and compatible with augmented and virtual reality devices.

“This is the first tool in the public domain that allows anyone, particularly non-experts in cheminformatics, to easily, visually and quickly access all this complex chemistry information in one place,” Fourches says. “This tool could help researchers better understand the chemical neighborhood of a particular compound. In fact, this is critical for drug repurposing or chemical risk assessment.”

The research appears in Bioinformatics. Dr. Alex Borrel, former NC State postdoctoral fellow currently at the NIEHS and first author of the paper, created the program. Fourches conceived ChemMaps and is corresponding author. Dr. Nicole Kleinstreuer, computational biologist at the NIEHS, also contributed to the work.

SOURCE: North Carolina State University


Filed Under: Drug Discovery

 

Related Articles Read More >

If Trump gets Europe to pay more for drugs, more new medicines could follow — eventually
Antibody - visual concept of immune System - 3D illustration
Fresenius picks the biosimilars, WuXi Biologics builds them in a deal covering up to 37 candidates
Physician in a white coat reviewing information on a tablet with a patient in an exam room.
What real-world data shows about current cancer care
Roche Towers, Basel, Switzerland
Roche picks cancer targets, Hansoh builds the ADCs in deal with $400 million upfront
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Pharmaceutical Processing World
  • R&D World
  • Subscribe to our E-Newsletter
  • About Us
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE